CAT Sues Abbott Over Humira Royalties
U.K. biotech company Cambridge Antibody Technology (CAT) filed a lawsuit in the High Court against Abbott Laboratories over hundreds of millions of dollars in royalty payments....To view the full article, register now.
Already a subscriber? Click here to view full article